// App-Quantinova.ai

4367 : Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

Researchers

Presenter

  • Janelle D Vaughns

Principal Investigators

  • Nicole Verdun

  • Elaine Williams

  • Victoria Ziesenitz

  • Evan P Nadler

  • John van den Anker

Medical Centers

  • University Clinic Heidelberg, Heidelberg, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Obesity

Biomarkers

  • Body mass index

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

Outcome

  • N/A


Study Design

  • pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim